Jeena Sikho Lifecare Limited Publishes Multiple Case Studies in International Ayurvedic Journals
Jeena Sikho Lifecare Limited has published several case studies and case reports authored by its medical professionals, including its Managing Director, senior consultants, and Ayurvedic experts. These publications affirm the company's continuous dedication to advancing Ayurvedic research and evidence-based clinical practice.The research has appeared in prominent international journals, including the International Journal of Ayurveda and Herbal Research (IJAHR), the Journal of Ayurveda and Integrated Medical Sciences (JAIMS), and Ayurvidya Adhyan: Global Journal of Ayurveda, Yoga and Integrative Medicine.
The company released details of the published research, which covers a range of complex medical conditions managed through Ayurvedic interventions.
Key Published Research
The publications provide detailed insights into various clinical cases. The studies are categorized as Case Studies or Case Reports and focus on holistic management approaches.The company compiled a list of 13 published research papers. The details are presented below:
| S. No. | Type | Title | Link |
|---|---|---|---|
| 1 | Case Study | Ayurvedic Management Of Uchcharaktachap: A Clinical Case And Therapeutic Insights | https://ahr.a2zjournals.com/index.php/ahr/article/view/147 |
| 2 | Case Study | Arbuda with Yakrit Ashrita Roga: An Ayurvedic Case Study on Gastrointestinal Stromal Tumor with Liver Metastasis | https://ahr.a2zjournals.com/index.php/ahr/article/view/152/105 |
| 3 | Case Report | Management of Vrikka Vikara (CKD) and Raktagata Vata (HTN): A Case Report | https://ahr.a2zjournals.com/index.php/ahr/article/view/148/101 |
| 4 | Case Study | A Comprehensive Review of Ayurvedic Interventions in the Management of Chronic Kidney Disease: A Case Study | https://ahr.a2zjournals.com/index.php/ahr/article/view/150/103 |
| 5 | Case Study | Management of Vrikka vikara (Chronic Kidney Disease) Through Ayurveda: A Holistic Approach | https://ahr.a2zjournals.com/index.php/ahr/article/view/149 |
| 6 | Case Report | Integrated Ayurvedic Management of Chronic Kidney Disease, Hypertension, and Diabetes: A Case Report | https://ahr.a2zjournals.com/index.php/ahr/article/view/151/104 |
| 7 | Case Study | Ayurveda-Based Integrative Therapeutics for Vandhyatva (Female Infertility): A Clinical Case Study | https://jaims.in/jaims/article/view/6516 |
| 8 | Case Study | Clinical Management of Beej Granthi (Ovarian Cyst) through Nidan Parivarjana, Ahar-Vihar Regulation, and Shamana Chikitsa: A Case Study | https://jaims.in/jaims/article/view/6519 |
| 9 | Case Study | Management of Stana Granthi (Fibroadenosis) through Kapha-Vata Shamana and Amapachana: A Case Study | https://jaims.in/jaims/article/view/6520 |
| 10 | Case Study | Kumbha Kamala: An Ayurvedic Approach to Liver Cirrhosis Management - A Case Study | https://www.vedadhyan.com/media/post/AYUR-2-3-2.1.pdf |
| 11 | Case Study | Madyapan Janita-Yakrit-Rogah: A Case Study on Ayurvedic Management | https://www.vedadhyan.com/media/post/AY UR-2-3-3.1.pdf |
| 12 | Case Study | Vrikk Vyadhi Chikitsa: AnAyurvedic Case Study on Complete Management of Chronic Kidney Disease | https://www.vedadhyan.com/media/post/AY UR-2-3-5.1.pdf |
| 13 | Case Study | A Case Study on the Ayurvedic Management of End-Stage CKD with Type II Diabetes Mellitus and Hypertension: Restoring Balance and Health | https://www.vedadhyan.com/media/post/AY UR-2-3-4.1.pdf |
Manish Grover, Managing Director of Jeena Sikho Lifecare Limited, confirmed the availability of the articles and case studies online. The company's commitment to medical research underscores its focus on integrated and evidence-based healthcare solutions.
JSLL Stock Price Movement
Jeena Sikho Lifecare Limited shares on Monday slipped by 2.27% to settle at ₹635.3. The stock traded on a volume of 573,562 shares, marking a significant drop from its previous closing price of ₹649.75.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: